Effect of prior anti-IL5 treatment on benralizumab outcomes in severe asthma

Severe asthma

Chair(s): Stylianos Loukides, Fabio L. M. Ricciardolo

Session type: Poster session

Gael Tavernier

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Effect of prior anti-IL5 treatment on benralizumab outcomes in severe asthma

Gael Tavernier

Poster

Abstract

What adds the new definition of bronchodilator responsiveness in asthmatic adults?

Hela Fakhfakh

Poster

Abstract

Effects of benralizumab therapy in patients with severe eosinophilic asthma: a single-center experience

Borislav Bozanic

Poster

Abstract

Effects of anti-IL5 receptor ? in severe asthma: a real-life study

Francesco Ardesi

Poster

Abstract

Assessment of the impact of infection SARS-CoV-2 on the control and Lung function of patients with severe asthma

Ana Pedro Cunha Craveiro

Poster

Abstract

Characterisation of asthma in patients with fixed obstructive ventilatory disorder

Ines Moussa

Poster

Abstract

Small airway changes assessed by impulse oscillometry in severe asmathic patients treated with Benralizumab

Cristina De Juana Izquierdo

Poster

Abstract

Adrenal insufficiency in corticosteroids dependent asthma: a single center experience

Erica Falzone

Poster

Abstract

A retrospective real-life study on the switch of biologics in severe asthma

Sonia Garino

Poster

Abstract

Parasite screening in a large pre-biologic severe eosinophilic asthma population

Irene Berrar Torre

Poster

Abstract

Severe Asthma Questionnaire (SAQ) And Asthma Control Questionnaire (ACQ) As Early Predictors Of Biologic Response In Severe Asthma.

Drew Davies

Poster

Abstract

Effectiveness of anti-IL5 biologics in severe asthma, based on real world observational studies: a systematic review

Dimitrios Potonos

Poster

Abstract

Head-to-head comparison between biologics in severe asthma: a real-world study

Elisa Riccardi

Poster

Abstract

Well-controlled severe asthmatics: who they really are?

Venere Piluso

Poster

Abstract

Persistent airflow limitation in severe asthma: should we talk about a specific phenotype?

Francesca Cefaloni

Poster

Abstract

Characteristics of severe asthma patients and predictors of asthma control in the Swiss Severe Asthma Registry

Fabienne Jaun

Poster

Abstract

The effect of anti-IL-5 biologics on lung function in adults with severe eosinophilic asthma.

Samuel Wallbanks

Poster

Abstract

Improved spirometric and oscillometric indices in severe asthma with clinical remission by anti-IL-5/IL-5 receptor alpha antibodies

Taisuke Akamatsu

Poster

Abstract

Phenotyping severe asthma attacks in patients hospitalised with acute asthma

Mouaid Aljehani

Poster

Abstract

Late Breaking Abstract - Novel Index assesses severe asthma care across 29 OECD countries

Patrick Gallen

Poster

Abstract

The ERS International Congress 2023, Milan

#{title}